Accession Number: | 0001179110-20-005297 |
Date: | 2020-04-28 |
Issuer: | THERAVANCE BIOPHARMA, INC. (TBPH) |
Original Submission Date: |
GUNDERSON ROBERT V JR
GUNDERSON DETTMER STOUGH
1200 SEAPORT BLVD
REDWOOD CITY, CA 94063
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2020-04-28 | A | 6,635 | a | $0.00 | 58,265 | direct | ||
ORDINARY SHARES | 2020-04-28 | 0 | $0.00 | 10,847 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SHARE OPTION (RIGHT TO BUY) | 30.14 | 2020-04-28 | deemed execution date | A | 6,000 (a) | 2030-04-27 | ordinary shares 6,000 | $30.14 | 6,000 | direct |
ID | footnote |
---|---|
f1 | this option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. |